Showing results (731-740 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry EyeMin Zhong, Thomas R Gadek, Minna Bui, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 ReplicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic DiarylaminesRaghavan Rajagopalan, Tien-Sung Lin, Amolkumar S Karwa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy AgentsAlla Darwish, Megan Blacker, Nancy Janzen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injuryDavid B Guthrie, Donald G Stein, Dennis C Liotta, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted AgentsRobert L Dow, Philip A Carpino, Denise Gautreau, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal CysteineAndrea Armirotti, Elisa Romeo, Stefano Ponzano, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full AgonistsHiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid AnaloguesHuayun Deng, Ye Fang
ACS Medicinal Chemistry Letters|June 6, 2014
Imidazo[1,2-a]pyridines That Directly Interact with Hepatitis C NS4B: Initial Preclinical CharacterizationJ Brad Shotwell, Subramanian Baskaran, Pek Chong, et al.
Pageof 438